Connecticut et al v. Aurobindo Pharma USA, Inc. et al

  1. July 22, 2024

    Price-Fixing Claims Against Par Pharma On Chopping Block

    A Connecticut federal judge has asked a coalition of states to explain why he shouldn't toss two price-fixing lawsuits against Par Pharmaceutical Companies Inc., noting that the defendant and its parent, Endo International PLC, recently filed Chapter 11 reorganization plans shielding them from the cases.

  2. July 01, 2024

    State AGs Get Stay Lifted In Generic Drug Pricing Litigation

    A Connecticut federal judge on Monday agreed to lift a partial discovery stay in a trio of generic drug pricing antitrust suits led by the attorneys general of New York and Connecticut, according to a short, text-only order posted to each of the case dockets.

  3. June 27, 2024

    State AGs Want Stay Lifted In Generic Drug Pricing Suit

    The attorneys general of New York and Connecticut have asked a federal judge to lift a partial discovery stay in three state-led generic drug pricing lawsuits against the pharmaceutical industry, saying it is no longer necessary because sentencing is complete in a parallel U.S. Department of Justice proceeding.

  4. June 03, 2024

    Drug Cos. Can Depose DC AG In Drug Price-Fixing Row

    A Connecticut federal judge reluctantly ordered the District of Columbia Attorney General's Office to be deposed by the drug companies wrapped up in more than 40 states' claims over an alleged price-fixing conspiracy, noting that he would not have done so but for the case being remanded from a sprawling multidistrict litigation in Pennsylvania.

  5. April 25, 2024

    Conn. Judge In Drug Price-Fixing Suit Reveals Day Pitney Ties

    U.S. District Judge Michael P. Shea of the District of Connecticut said Thursday he will not recuse himself from overseeing state enforcers' price-fixing claims against Sandoz Inc. and other drug companies despite Sandoz's attorneys being from Day Pitney LLP, where he was once a partner.

  6. February 01, 2024

    State-Led Generic Drug Cases Removed From MDL

    The Judicial Panel on Multidistrict Litigation has sent a trio of cases from state-level enforcers back to federal court in Connecticut, separating them from the sprawling MDL centralized in Pennsylvania over claims of price fixing in the generic drug industry.

  7. May 23, 2017

    40 States Defend Power To Bring Generic-Drug Price-Fix Suit

    Forty states on Monday defended their lawsuit against six generic-drug manufacturers alleging they divided the market and fixed the price of an antibiotic and a diabetes treatment, saying they have the authority to seek an injunction and monetary relief under federal antitrust law.

  8. May 03, 2017

    Generic-Drug Makers Want 40-State Price-Fix Suit Dropped

    Six generic-drug makers accused of conspiring to fix the prices of an antibiotic and a diabetes medication have asked a Connecticut federal court to toss the suit now joined by 40 states, saying the complaint contains a multitude of legal flaws.

  9. March 01, 2017

    20 More States Join Generic Drug-Pricing Antitrust Action

    Forty states are now bringing antitrust claims against six generic-drug makers including Heritage, Mylan and Teva, alleging they conspired to fix the prices of an antibiotic and a diabetes medication, according to an amended complaint filed in Connecticut federal court Wednesday.

  10. February 09, 2017

    Feds Look To Intervene In 20-State Drug Antitrust Suit

    The U.S. government on Thursday asked a Connecticut federal court for permission to intervene in an antitrust action from 20 states against six generic-drug makers including Heritage, Mylan and Teva, citing the need to "protect the integrity" of its own investigation into the generic pharmaceutical industry.